首页> 美国卫生研究院文献>other >WHICH CLINICAL/PATHOLOGIC FACTORS MATTER IN THE ERA OF CHEMORADIATION AS TREATMENT FOR LOCALLY ADVANCED CERVICAL CARCINOMA? ANALYSIS OF TWO GYNECOLOGIC ONCOLOGY GROUP (GOG) TRIALS

【2h】

WHICH CLINICAL/PATHOLOGIC FACTORS MATTER IN THE ERA OF CHEMORADIATION AS TREATMENT FOR LOCALLY ADVANCED CERVICAL CARCINOMA? ANALYSIS OF TWO GYNECOLOGIC ONCOLOGY GROUP (GOG) TRIALS

机译：在化学放射时代哪些临床/病理因素对局部晚期宫颈癌的治疗有重要意义？两次妇科肿瘤试验的分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo explore clinical/pathologic factors associated with prognosis of patients with locally advanced cervical carcinoma treated with weekly cisplatin and pelvic radiation.

机译：目的探讨每周顺铂联合盆腔放疗治疗的局部晚期宫颈癌患者预后的临床/病理因素。

著录项

期刊名称 other
作者
Bradley J. Monk; Chunqiao Tian; Peter G. Rose; Rachelle Lanciano;
展开▼
作者单位

展开▼
年(卷),期 -1(105),2
年度 -1
页码 427–433
总页数 14
原文格式 PDF
正文语种
中图分类
关键词
cervical cancer radiation chemotherapy clinicopathologic prognosis;

机译：子宫颈癌;放射线;化学疗法;临床病理;预后;

相似文献

外文文献
中文文献
专利

1. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy [J] . Rose Peter G., Java James, Whitney Charles W., Journal of Clinical Oncology . 2015,第19期

机译：通过对NRG肿瘤/妇科肿瘤组化学放疗的随机预后因素进行分析，可预测局部晚期宫颈癌的无进展生存期，总生存期和盆腔复发的线型图
2. Risk Factors for Readmission in Patients With Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Who Are Receiving Front-line Chemotherapy on a Clinical Trial (GOG 218): An NRG Oncology/Gynecologic Oncology Group Study (ADS-1236) EDITORIAL COMMENT [J] . Van Le Linda Obstetrical and gynecological survey . 2016,第1期

机译：在临床试验中接受一线化疗的卵巢癌，输卵管癌和原发性腹膜癌患者再次入院的危险因素（GOG 218）：NRG肿瘤/妇科肿瘤学组研究（ADS-1236）编辑评论
3. Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236) [J] . Duska Linda R., Java James J., Cohn David E., Gynecologic Oncology: An International Journal . 2015,第2期

机译：在临床试验中接受一线化疗的卵巢癌，输卵管癌和原发性腹膜癌患者再次入院的危险因素（GOG 218）：NRG肿瘤/妇科肿瘤组研究（ADS-1236）
4. IL-12 is a Useful Marker to Predict Clinical Outcome in Radiotherapy: Down-Regulation of IL-12 Increases Treatment Failure in Locally Advanced Hepatocellular Carcinoma [C] . En-Jung Lee, Yan-Gun Suh, Seojin Lee, International Molecular Medicine Tri-Conference. . 2015

机译：IL-12是一种有用的标记，可预测放疗中的临床结果：IL-12的下调增加了局部晚期肝细胞癌的治疗失败
5. Adaptive Radiation Therapy Planning Using Fluorodeoxyglucose PET -- Locally Advanced Cervical Cancer. [D] . Mehta, Par. 2011

机译：使用氟脱氧葡萄糖PET进行的适应性放射治疗计划-局部晚期宫颈癌。
6. Factors Associated With Grade 3-4 Treatment-Related Toxicity In Women With Advanced Or Recurrent Cervical Cancer: An Exploratory Analysis Of NRG Oncology/Gynecologic Oncology Group Trials (GOG) 179 And 204 [O] . Dana M. Chase, James Kauderer, Lari Wenzel, -1

机译：患有晚期或复发性宫颈癌的妇女中与3-4级治疗相关的毒性相关的因素：NRG肿瘤/妇科肿瘤组试验（GOG）179和204的探索性分析
7. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy [O] . Rose, Peter G., Java, James, Whitney, Charles W., 2015

机译：通过对NRG肿瘤/妇科肿瘤组化学放疗的随机预后因素进行分析，可预测局部晚期宫颈癌的无进展生存期，总生存期和盆腔复发的线型图

WHICH CLINICAL/PATHOLOGIC FACTORS MATTER IN THE ERA OF CHEMORADIATION AS TREATMENT FOR LOCALLY ADVANCED CERVICAL CARCINOMA? ANALYSIS OF TWO GYNECOLOGIC ONCOLOGY GROUP (GOG) TRIALS

摘要

著录项

相似文献

相关主题

期刊订阅